TrialAging cell2023

Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin.

Michael Vreones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.